Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on the sale of Kaelus to Baylin Technologies
Mandate

Vinge advises on the sale of Kaelus to Baylin Technologies

December 01, 2025 M&A EU, Competition and Regulatory

Baylin Technologies, listed on the Toronto Stock Exchange, has entered into an agreement to acquire all shares in the Swedish company, Kaelus for approximately SEK 285 million with the aim of creating a global leader in wireless technology.

The transaction is subject to customary regulatory approvals.

Vinge advised the shareholders of Kaelus primarily through Johan Winnerblad, Per Kling, Emma Lundberg and Fredrik Hellström.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026